Philips Foundation 2024 Annual Report: expanding access to quality healthcare for 46.5 million people
Philips announces exchange ratio for 2024 dividend
Citi transfers ALC, ALC.SW, AMP.IM, others
Philips to repurchase up to 6 million shares to cover long-term incentive plans
Australia's TGA initiates court proceedings against Philips Electronics Australia Limited (earlier) (€19.68, -0.20)
StreetAccount Summary - US Pre-market trading
Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures
Apnimed (private) announced topline results in the first phase 3 clinical trial of AD109, an investigational once-daily oral pill for obstructive sleep Apnea (yesterday pre-open)
Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures
Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects
Powered by FactSet Research Systems Inc.